Dapsone Structure (710844ec 6a59 45fa B72a 4d75a4857361 01)
Dapsone Tablet
Product Images NDC 72578-178
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 72578-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dapsone Tablets,25 mg (710844ec 6a59 45fa B72a 4d75a4857361 02)
This text provides information on Dapsone Tablets, USP, containing 25mg of Dapsone. It advises to store the tablets at temperatures between 20°C to 25°C and protect them from light. The package is child-resistant and should be kept away from children. It is manufactured by Zydus Pharmaceuticals Ltd. in India and distributed by Viona Pharmaceuticals Inc. in Cranford, NJ. Dosage instructions and further details are available in the accompanying literature.*
Dapsone Tablets, 100mg (710844ec 6a59 45fa B72a 4d75a4857361 03)
This is a prescription medication with each tablet containing 100 mg of Dapsone, USP. The usual dosage should be followed as per accompanying literature. It is important to store the tablets between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F), and protect from light. The packaging is child-resistant, and the tablets should be kept out of the reach of children. The medication is manufactured by Zydus Pharmaceuticals Ltd. in India and distributed by Viona Pharmaceuticals Inc. in Cranford, NJ. Each package contains 30 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
